Catherine M Spier Selected Research

Radioimmunotherapy

1/2018

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine M Spier Research Topics

Disease

4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 10/2006
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 06/2004
3	Lymphoma (Lymphomas) 01/2013 - 06/2004
2	COVID-19 11/2020 - 08/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2008 - 06/2004
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2013
1	Leukemia 06/2004
1	Neoplasms (Cancer) 06/2004

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2006
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 05/2008
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 05/2008
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 05/2008
2	Rituximab (Mabthera)FDA Link 01/2018 - 05/2008
1	Neutralizing AntibodiesIBA 11/2020
1	AntibodiesIBA 11/2020
1	IodineIBA 01/2018
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2015
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 08/2014
1	Anaplastic Lymphoma KinaseIBA 01/2013
1	Methylprednisolone FDA LinkGeneric 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Gemcitabine FDA Link 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 01/2013
1	Biological ProductsIBA 05/2008
1	DNA (Deoxyribonucleic Acid)IBA 06/2004

Therapy/Procedure

3	Radiotherapy 01/2015 - 10/2006
2	Drug Therapy (Chemotherapy) 01/2015 - 10/2006
1	Radioimmunotherapy 01/2018
1	Aftercare (After-Treatment) 01/2018